Search results for "clarithromycin"

showing 10 items of 35 documents

Computational analysis of macrolides as SARS-CoV-2 main protease inhibitors: a pattern recognition study based on molecular topology and validated by…

2021

Since the outbreak of the current SARS-CoV-2 pandemic, much has been discussed about the effectiveness of treatments based on hydroxychloroquine combined with azithromycin or another macrolide. However, few articles have dealt with the possibility of using macrolides alone in treating the disease. In the present article, the authors' hypothesis centers on the possibility that macrolides are effective against SARS-CoV-2 by inhibiting the virus protease. In support of this hypothesis, significant results are collected by following an in silico strategy based on a combination of molecular topology and docking. The results are in accordance with recent clinical data generated during the pandemi…

0301 basic medicineProteaseChemistryIn silicomedicine.medical_treatmentGeneral ChemistryComputational biologyAzithromycinFlurithromycinCatalysisVirus03 medical and health sciences030104 developmental biology0302 clinical medicineDocking (molecular)030220 oncology & carcinogenesisClarithromycinMaterials ChemistrymedicineViral loadmedicine.drugNew Journal of Chemistry
researchProduct

Epidemiology and clinical features of Mediterranean spotted fever in Italy

2006

Mediterranean Spotted Fever is caused by Rickettsia conorii and is transmitted to humans by Rhipicephalus sanguineus, the common dog tick. It is characterized by the symptomatologic triad: fever, exanthema and "tache noire", the typical eschar at the site of the tick bite. In Italy the most affected region is Sicily. The seasonal peak of the disease (from June through September) occurs during maximal activity of immature stage ticks. Severe forms of the disease have been reported in 6% of patients, especially adults with one of the following conditions: diabetes, cardiac disease, chronic alcoholism, glucose-6-phosphate dehydrogenase deficiency, end stage kidney disease. The mortality rate m…

AdultAlanine TransaminaseComorbidityRhipicephalus sanguineusSpotted Fever boutonneuse fever Rickettsia clarithromycin azithromycinBoutonneuse FeverThrombocytopeniaAnti-Bacterial AgentsRickettsia conoriiItalyAnimalsHumansKidney Failure ChronicArachnid VectorsAspartate AminotransferasesBites and StingsSeasonsChild
researchProduct

Lack of significant differences between gastrointestinal tract microbial population structure of Helicobacter pylori-infected subjects before and 2 y…

2020

Background According to recent estimates 80% of Latvian population is infected with Helicobacter pylori thus their susceptibility to numerous gastric tract diseases is increased. The 1st line H. pylori eradication therapy includes treatment with clarithromycin in combination with amoxicillin or metronidazole and a proton pump inhibitor. However, potential adverse events caused by such therapies to microbiome are insufficiently studied. Objective This study aimed to evaluate the long-term effect of H. pylori eradication on human gastrointestinal tract (GIT) microbiome. Methods The assessment of H pylori eradication impact on GIT microbiome was done by analyzing 120 samples acquired from 60 s…

AdultMalemedicine.medical_specialtyPopulationGastroenterologyHelicobacter Infections03 medical and health sciences0302 clinical medicineInternal medicineClarithromycinClarithromycinMetronidazolemedicineHumansMicrobiomeeducationeducation.field_of_studybiologybusiness.industryGastroenterologyAmoxicillinProton Pump InhibitorsGeneral MedicineHelicobacter pyloriAmoxicillinMiddle Agedbiology.organism_classificationLatviaAnti-Bacterial AgentsGastrointestinal MicrobiomeMetronidazoleInfectious Diseases030220 oncology & carcinogenesis030211 gastroenterology & hepatologyEnterotypeDrug Therapy CombinationFemaleSample collectionbusinessmedicine.drugHelicobacterREFERENCES
researchProduct

Glossitis, stomatitis, and black tongue with lansoprazole plus clarithromycin and other antibiotics

1997

AdultMalemedicine.medical_specialtyglossitiGlossitismedicine.drug_classAntibioticsadverse drug reactionLansoprazole2-PyridinylmethylsulfinylbenzimidazolesGlossitisPharmacotherapyTongueClarithromycinClarithromycinmedicineAdverse Drug Reaction Reporting SystemsHumansPharmacology (medical)StomatitisAgedStomatitisbusiness.industryMiddle AgedAnti-Ulcer Agentsmedicine.diseaselansoprazoleDermatologyAnti-Bacterial Agentsmedicine.anatomical_structureDrug Therapy CombinationFemalebusinessclarythromicinOmeprazoleAdverse drug reactionmedicine.drug
researchProduct

The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients.

1996

BACKGROUND: The combination of omeprazole with amoxycillin or clarithromycin is used as treatment against Helicobacter pylori. It seems likely that the antibacterial activity of the antibiotic may be improved by increasing gastric pH towards neutrality, and a twice daily regimen of omeprazole is probably needed. AIM: To assess the effects of twice daily administration of omeprazole 20 and 40 mg. METHODS: Twelve duodenal ulcer patients in remission were randomized to receive in single-blind fashion either placebo, omeprazole 20 mg or omeprazole 40 mg twice daily (08.00 and 20.00 h). On the sixth day of dosing they underwent 24-h gastric pH-metry. RESULTS: Omeprazole 20 and 40 mg b.d. produce…

AdultMalemedicine.medical_specialtymedicine.drug_classProton-pump inhibitorGastroenterologyHelicobacter InfectionsGastric AcidInternal medicineClarithromycinmedicineHumansSingle-Blind MethodPharmacology (medical)Enzyme InhibitorsOmeprazoleGastric Acidity DeterminationCross-Over StudiesHelicobacter pyloriHepatologybiologybusiness.industryStomachGastroenterologyProton Pump InhibitorsGastric Acidity DeterminationMiddle AgedHelicobacter pyloribiology.organism_classificationCrossover studyCircadian Rhythmmedicine.anatomical_structureDuodenal UlcerDuodenumFemalebusinessOmeprazolemedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in I…

2021

Background: Information on the management of Helicobacter (H.) pylori infection by gastroenterologists and gastroenterology fellows are scarce. We aimed to assess practice of gastroenterologists and gastroenterology fellows and their adherence to guidelines for diagnosis and treatment of H. pylori infection in Italy. Materials and Methods: All gastroenterologists and gastroenterology fellows attending the National Congress of Digestive Diseases - FISMAD were invited to fill-in an on-line questionnaire. The questionnaire included questions on the diagnosis and treatment of H. pylori infection. Results: A total of 279 gastroenterologists and 61 gastroenterology fellows participated to the stu…

Background informationHelicobacter pylori infectionmedicine.medical_specialtygenetic structuresdiagnosisgastroenterology fellowGastroenterologyHelicobacter pylori; diagnosis; gastroenterologists; gastroenterology fellows; guidelines; treatment; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy Combination; Humans; Proton Pump Inhibitors; Surveys and Questionnaires; Gastroenterologists; Gastroenterology; Helicobacter Infections; Helicobacter pyloriHelicobacter InfectionsDrug TherapyClarithromycinInternal medicineClarithromycinSurveys and QuestionnairesMedicineHumansguidelinesbiologyHelicobacter pyloritreatmentbusiness.industryGastroenterologistsGastroenterologyAmoxicillinProton Pump InhibitorsGeneral MedicineHelicobacter pyloribiology.organism_classificationeye diseasesAnti-Bacterial AgentsdiagnosiInfectious Diseasesgastroenterology fellowsThird lineCombinationDrug Therapy CombinationgastroenterologistEducational interventionsbusinessguidelineBismuthmedicine.drug
researchProduct

Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infe…

1999

Background: Ranitidine bismuth citrate (RBC) co-prescribed with clarithromycin and metronidazole for 1 week has been shown to be an effective eradicating regimen for Helicobacter pylori. Aim: To determine the optimal duration of this regimen. Methods: A series of 165 dyspeptic patients were recruited for this randomized, open, parallel-group study. They were subdivided into three groups receiving RBC 400 mg b.d. plus clarithromycin 250 mg b.d. and metronidazole 500 mg b.d. for three different periods (4, 7 and 10 days). H. pylori infection was assessed by the concomitant positivity of CLO-test and histology performed at the pre-entry endoscopy. The bacterium was considered eradicated on the…

Breath testmedicine.medical_specialtyIntention-to-treat analysisHepatologymedicine.diagnostic_testbiologybusiness.industryGastroenterologyHelicobacter pyloribiology.organism_classificationGastroenterologySurgeryRanitidineMetronidazoleRegimenInternal medicineClarithromycinmedicinePharmacology (medical)businessAntibacterial agentmedicine.drugAlimentary Pharmacology & Therapeutics
researchProduct

Neglected diseases caused by bacterial infections.

2009

Bacterial infections represent a major health problem, especially in third world countries. In endemic regions, large populations of people are greatly affected, but the medical care is very limited. In this review, the neglected diseases buruli ulcer and trachoma are elucidated. Buruli ulcer is caused by Mycobacterium ulcerans which produces an outstanding immunosuppressive toxin mycolactone that induces an ulcerative, necrotic skin disease. Until today, only the combination of rifampin/streptomycin is used to treat buruli ulcer. However, this therapy is ineffective and expensive. Here, we report new findings that suggest pharmaceutical formulations such as rifapentine, in combination with…

Buruli ulcerChlamydia trachomatismedicine.disease_causeAzithromycinBiochemistryMicrobiologychemistry.chemical_compoundRare DiseasesPersonal hygieneClarithromycinDrug DiscoverymedicineAnimalsHumansMycolactoneBuruli UlcerPharmacologyTrachomabiologyMycobacterium ulceransbusiness.industryOrganic ChemistryVaccinationmedicine.diseasebiology.organism_classificationAnti-Bacterial AgentsTrachomachemistryMycobacterium ulceransImmunologyMolecular MedicineChlamydia trachomatisbusinessmedicine.drugCurrent medicinal chemistry
researchProduct

Dissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation–lyophilization–homogenization method

2014

The gastroduodenal diseases caused by Helicobacter pylori were commonly treated with antibiotic clarithromycin as a standard regimen. According to the poorly water-soluble of clarithromycin, the nanocrystal formulation was prepared. The aim of this study was to investigate an enhancement effect of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization (PLH) method on the saturation solubility, dissolution velocity, antibiotic activity, permeability through the gastric mucus and cellular permeability. Poloxamer 407 and sodium lauryl sulfate (SLS) were chosen as combined stabilizers in the nanocrystal system. The obtained clarithromycin nanocrystals were identifie…

Cell SurvivalChemistry PharmaceuticalPopulationPharmaceutical ScienceMineralogychemistry.chemical_compoundFreeze-dryingClarithromycinClarithromycinpolycyclic compoundsmedicineChemical PrecipitationHumansSolubilityeducationDissolutioneducation.field_of_studyDose-Response Relationship DrugPrecipitation (chemistry)ChemistryGeneral MedicineBuffer solutionbacterial infections and mycosesAnti-Bacterial AgentsFreeze DryingSolubilityPoloxamer 407NanoparticlesCaco-2 CellsBiotechnologymedicine.drugNuclear chemistryEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Impact of uncharged and charged stabilizers on in vitro drug performances of clarithromycin nanocrystals

2018

The purpose of this study was to evaluate the effect of charge on the in vitro drug performances of clarithromycin nanocrystals. To prepare different charges of nanocrystals, media milling was employed with the use of different stabilizing systems. The uncharged nanocrystals were prepared from poloxamer 407. The negatively and positively charged nanocrystals were stabilized using a combination of poloxamer 407 with sodium lauryl sulfate (SLS) and cetyltrimethylammonium bromide (CTAB), respectively. After production, the particle size of the negatively and positively charged nanocrystals was smaller than that of the uncharged one. The similar particle size of variously charged clarithromycin…

Chemistry PharmaceuticalDrug CompoundingPharmaceutical SciencePoloxamer02 engineering and technology030226 pharmacology & pharmacyCell LineExcipients03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBromideClarithromycinMonolayermedicineHumansSurface chargeParticle SizeSolubilityDissolutionCetrimoniumChemistrySodium Dodecyl SulfateBiological TransportGeneral Medicine021001 nanoscience & nanotechnologyAnti-Bacterial AgentsDrug LiberationSolubilityChemical engineeringNanocrystalPoloxamer 407NanoparticlesParticle sizeCaco-2 Cells0210 nano-technologyBiotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct